Delivery Order SPE2DB25D3020-SPE2DB25FWKMG
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Clomid 50 mg tablets in unit dose packaging of 30 units. This is a competitively awarded, non-set-aside firm fixed price delivery order valued at $4,370.26, with an ultimate completion date of August 22, 2025. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Clomid 50 mg tablets in unit dose packaging (30 count) with a ceiling value of $3,506.24. This competitive delivery order, which employs firm fixed price contracting, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The order carries no set-aside designation and is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Clomid 50 mg tablets in unit dose packages of 30 units. This is a firm fixed price delivery order with a ceiling value of $1,454.00 and an ultimate completion date of September 12, 2025. The contract is non-set-aside and was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $17,470.05 on August 28, 2025, for the supply of Clomid 50 mg tablets in unit dose packaging (30-count). This firm fixed price, competitively awarded delivery order represents a non-set-aside procurement executed under the company's larger indefinite delivery contract with DLA Troop Support Medical. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,287.00 to AmerisourceBergen Drug Corp for the supply of Clomid 50 mg tablet unit dose packs (30 count) on July 29, 2025, with an ultimate completion date of July 30, 2025. This firm fixed-price contract was awarded on a competitive basis with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Clomid 50 mg tablets in unit dose packages of 30 units, with a contract ceiling value of $1,207.41. This competitively awarded, non-set-aside delivery order has a firm fixed price structure and an ultimate completion date of August 15, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a $10,034.90 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Clomid 50 mg tablets in unit dose packaging of 30-count quantities. The contract, which is not set-aside and was competitively awarded, has an ultimate completion date of September 3, 2025, with performance occurring at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,441.05 to AmerisourceBergen Drug Corp for the supply of Clomid 50 mg tablets in unit dose packages of 30 units. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of August 14, 2025, issued on August 13, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is performing the contract at its corporate office location. The delivery order is a child contract...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,945.45 to AmerisourceBergen Drug Corp for the supply of Clomid 50 mg tablets in unit dose packaging (30-count containers). The contract, issued on September 11, 2025, with an ultimate completion date of September 12, 2025, represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the prime...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Clomid 50 mg tablets in unit dose packaging of 30s, with a ceiling value of $1,140.26. This is a firm fixed price delivery order with an ultimate completion date of July 25, 2025, and represents a child contract under AmerisourceBergen's broader pharmaceutical supply agreements. The contract utilizes no set-aside designation and was competitively awarded through the federal...
- SPE2DB25D3020Indefinite Delivery Contract
- SPE2DB25D3020-SPE2DB25FWKMGDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Clomid 50 mg tablets in unit dose packaging (30 count) with a ceiling value of $1,281.55. This firm fixed price delivery order represents a non-competitive set-aside procurement and is scheduled for completion by September 9, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA's medical supply chain. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 through December 2026. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, and medical commodities to support military healthcare programs worldwide. AmerisourceBergen Drug Corp's substantial federal contract portfolio demonstrates its capability to fulfill diverse pharmaceutical requirements across multiple therapeutic domains in support of Defense Health Agency and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 9/8/25 |